Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.48 CNY
847.23 M CNY
2.84 B CNY
1.32 B
About ANHUI ANKE BIOTECH
Sector
CEO
Li Hua Song
Headquarters
Hefei
Website
Founded
1993
ISIN
CNE100000GY2
FIGI
BBG000NWBC40
Anhui Anke Biotechnology (Group) Co., Ltd. engages in the research, development, manufacturing, and sale of biopharmaceutical products. The firm provides the implementation of precision medical development strategy; the formation of genetic testing, and the development of anti-tumor drugs and cell immunotherapy technology. Its products include biological products, modern Chinese medicine, chemical synthesized drugs, diagnostic reagents, DNA testing, functional food and functional skin care. The company was founded by Li Hua Song in May 1993 and is headquartered in Hefei, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300009 is 9.01 CNY — it has increased by 0.33% in the past 24 hours. Watch ANHUI ANKE BIOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange ANHUI ANKE BIOTECH stocks are traded under the ticker 300009.
300009 stock has fallen by −2.59% compared to the previous week, the month change is a −2.49% fall, over the last year ANHUI ANKE BIOTECH has showed a −11.14% decrease.
300009 reached its all-time high on May 20, 2021 with the price of 19.27 CNY, and its all-time low was 1.28 CNY and was reached on Jul 31, 2012. View more price dynamics on 300009 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300009 stock is 1.56% volatile and has beta coefficient of 1.42. Track ANHUI ANKE BIOTECH stock price on the chart and check out the list of the most volatile stocks — is ANHUI ANKE BIOTECH there?
Today ANHUI ANKE BIOTECH has the market capitalization of 14.69 B, it has decreased by −2.95% over the last week.
Yes, you can track ANHUI ANKE BIOTECH financials in yearly and quarterly reports right on TradingView.
ANHUI ANKE BIOTECH is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
300009 net income for the last quarter is 173.59 M CNY, while the quarter before that showed 198.38 M CNY of net income which accounts for −12.50% change. Track more ANHUI ANKE BIOTECH financial stats to get the full picture.
Yes, 300009 dividends are paid annually. The last dividend per share was 0.25 CNY. As of today, Dividend Yield (TTM)% is 2.77%. Tracking ANHUI ANKE BIOTECH dividends might help you take more informed decisions.
ANHUI ANKE BIOTECH dividend yield was 2.45% in 2023, and payout ratio reached 48.23%. The year before the numbers were 2.67% and 58.14% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 2.99 K employees. See our rating of the largest employees — is ANHUI ANKE BIOTECH on this list?
Like other stocks, 300009 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANHUI ANKE BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANHUI ANKE BIOTECH technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANHUI ANKE BIOTECH stock shows the strong sell signal. See more of ANHUI ANKE BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.